135 related articles for article (PubMed ID: 2013210)
1. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
Wise R; Andrews JM; Ashby JP; Thornber D
Diagn Microbiol Infect Dis; 1991; 14(1):45-52. PubMed ID: 2013210
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
Doern GV
Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
[TBL] [Abstract][Full Text] [Related]
3. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Jones RN; Barry AL
Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
[TBL] [Abstract][Full Text] [Related]
5. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):89-92. PubMed ID: 2013215
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
Jones RN
Diagn Microbiol Infect Dis; 1991; 14(1):37-43. PubMed ID: 2013209
[TBL] [Abstract][Full Text] [Related]
7. Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action.
Wise R; Andrews JM; Ashby JP; Thornber D
J Antimicrob Chemother; 1990 Aug; 26(2):209-13. PubMed ID: 2120175
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1576-82. PubMed ID: 3190185
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Bauernfeind A; Jungwirth R
Infection; 1991; 19(5):353-62. PubMed ID: 1800377
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Doern GV; Tubert TA
Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
Chin NX; Gu JW; Neu HC
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
Verbist L; Jacobs J; Hens K
Diagn Microbiol Infect Dis; 1991; 14(1):53-61. PubMed ID: 1901535
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of BAY v 3522, a new oral cephalosporin.
Fass RJ
Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
15. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
Wise R; Andrews JM; Thornber D
J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies with Bay V 3522, a new oral cephalosporin.
Thomson KS; Sanders CC; Sanders WE
Drugs Exp Clin Res; 1991; 17(3):165-73. PubMed ID: 1914843
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Fuchs PC; Jones RN; Barry AL; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
Diagn Microbiol Infect Dis; 1986 Jul; 5(2):151-62. PubMed ID: 3522088
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of BMY-28100, a new oral cephalosporin.
Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
